{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:08:34Z","timestamp":1789679314151,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-023-02717-y","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T05:02:31Z","timestamp":1681707751000},"page":"3175-3184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of topical prostaglandin therapy on corneal layers thickness in primary open-angle glaucoma patients using anterior segment optical coherence tomography"],"prefix":"10.1007","volume":"43","author":[{"given":"Numan","family":"Eraslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Celikay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"2717_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0002-9394(14)76171-9","volume":"113","author":"EM Van Buskirk","year":"1992","unstructured":"Van Buskirk EM, Cioffi GA (1992) Glaucomatous optic neuropathy. Am J Ophthalmol 113:447\u2013452","journal-title":"Am J Ophthalmol"},{"key":"2717_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham Y-C, Li X, Wong TY et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081\u20132090","journal-title":"Ophthalmology"},{"key":"2717_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMra0804630","volume":"360","author":"YH Kwon","year":"2009","unstructured":"Kwon YH, Fingert JH, Kuehn MH et al (2009) Primary open-angle glaucoma. N Engl J Med 360:1113\u20131124","journal-title":"N Engl J Med"},{"key":"2717_CR4","first-page":"2040","volume":"15","author":"C Cavdarli","year":"2015","unstructured":"Cavdarli C, Yarangumeli A, Aki H, Kural G (2015) Short-term effects of latanoprost on intraocular pressure, central corneal thickness and anterior chamber depth in open-angle glaucoma. Int Eye Sci 15:2040\u20132044","journal-title":"Int Eye Sci"},{"key":"2717_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/bjophthalmol-2016-308432","volume":"101","author":"R Meda","year":"2017","unstructured":"Meda R, Wang Q, Paoloni D, Harasymowycz P et al (2017) The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucoma. Br J Ophthalmol 101:120\u2013125","journal-title":"Br J Ophthalmol"},{"key":"2717_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000303213","volume":"134","author":"H Goldmann","year":"1957","unstructured":"Goldmann H, Schmidt T (1957) About applanation tonometry. Ophthalmologica 134:221\u2013242","journal-title":"Ophthalmologica"},{"key":"2717_CR7","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/archopht.120.6.714","volume":"120","author":"MO Gordon","year":"2002","unstructured":"Gordon MO, Beiser JA, Brandt JD et al (2002) The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120:714\u2013720","journal-title":"Arch Ophthalmol"},{"key":"2717_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1089\/jop.2009.0007","volume":"25","author":"T Schlote","year":"2009","unstructured":"Schlote T, Tzamalis A, Kynigopoulos M (2009) Central corneal thickness during treatment with travoprost 0.004% in glaucoma patients. J Ocul Pharmacol Ther 25:459\u2013462","journal-title":"J Ocul Pharmacol Ther"},{"key":"2717_CR9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/bph.14327","volume":"176","author":"GK Peter","year":"2019","unstructured":"Peter GK, Najam AS (2019) Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma. Br J Pharmacol 176:1051\u20131058","journal-title":"Br J Pharmacol"},{"key":"2717_CR10","first-page":"790","volume":"115","author":"KS Lim","year":"2008","unstructured":"Lim KS, Nau CB, O\u2019Byrne MM et al (2008) Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study Ophthalmol 115:790\u2013795","journal-title":"A crossover study Ophthalmol"},{"key":"2717_CR11","first-page":"716","volume":"43","author":"RN Weinreb","year":"2002","unstructured":"Weinreb RN, Lindsey JD (2002) Metalloproteinase gene transcription in human ciliary muscle cells with latanoprost. Invest Ophthalmol Vis Sci 43:716\u2013722","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2717_CR12","first-page":"1475","volume":"43","author":"U Schl\u00f6tzer-Schrehardt","year":"2002","unstructured":"Schl\u00f6tzer-Schrehardt U, Zenkel M, N\u00fcsing RM (2002) Expression and localisation of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest Ophthalmol Vis Sci 43:1475\u20131487","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2717_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/02713680591006237","volume":"30","author":"KY Wu","year":"2005","unstructured":"Wu KY, Wang HZ, Hong SJ (2005) Effect of latanoprost on cultured porcine stromal cells. Curr Eye Res 30:871\u2013879","journal-title":"Curr Eye Res"},{"key":"2717_CR14","first-page":"95","volume":"51","author":"C Stefan","year":"2007","unstructured":"Stefan C, Dumitrica DM, Tebeanu E et al (2007) Prostaglandin analogues and central corneal thickness. Oftalmologia 51:95\u201399","journal-title":"Oftalmologia"},{"key":"2717_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/ICO.0b013e31802e3ce4","volume":"26","author":"PJ Harasymowycz","year":"2007","unstructured":"Harasymowycz PJ, Papamatheakis DG, Ennis M et al (2007) Travoprost central corneal thickness study group Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma. Cornea 26:34\u201341","journal-title":"Cornea"},{"key":"2717_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ophtha.2008.02.001","volume":"115","author":"JD Brandt","year":"2008","unstructured":"Brandt JD, Gordon MO, Beiser JA et al (2008) Changes in central corneal thickness over time: The ocular hypertension treatment study. Ophthalmology 115:1550\u20131556","journal-title":"Ophthalmology"},{"key":"2717_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/IJG.0b013e31815d784c","volume":"17","author":"E Sen","year":"2008","unstructured":"Sen E, Nalcacioglu P, Yazici A et al (2008) Comparison of the effects of latanoprost and bimatoprost on central corneal thickness. J Glaucoma 17:398\u2013402","journal-title":"J Glaucoma"},{"key":"2717_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/jop.2007.0125","volume":"25","author":"M Hatanaka","year":"2009","unstructured":"Hatanaka M, Vessani RM, Elias IR et al (2009) The effect of prostaglandin analogs and prostamide on central corneal thickness. J Ocul Pharmacol Ther 25:51\u201353","journal-title":"J Ocul Pharmacol Ther"},{"key":"2717_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1755-3768.2009.01731.x","volume":"89","author":"M Bafa","year":"2011","unstructured":"Bafa M, Georgopoulos G, Mihas C et al (2011) The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: A 2-year study on 129 eyes. Acta Ophthalmol 89:448\u2013451","journal-title":"Acta Ophthalmol"},{"key":"2717_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/ICU.0b013e328089f1c8","volume":"18","author":"RW Yee","year":"2007","unstructured":"Yee RW (2007) The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review. Curr Opin Ophthalmol 18:134\u2013139","journal-title":"Curr Opin Ophthalmol"},{"key":"2717_CR21","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1007\/s10792-021-01947-2","volume":"41","author":"OE Muz","year":"2021","unstructured":"Muz OE, Dagdelen K, Pirdal T et al (2021) Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension. Int Ophthalmol 41:3825\u20133835","journal-title":"Int Ophthalmol"},{"key":"2717_CR22","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.ophtha.2010.03.002","volume":"117","author":"SM Nam","year":"2010","unstructured":"Nam SM, Im CY, Lee HK et al (2010) Accuracy of RTVue optical coherence tomography, Pentacam, and ultrasonic pachymetry for the measurement of central corneal thickness. Ophthalmology 117:2096\u20132103","journal-title":"Ophthalmology"},{"key":"2717_CR23","doi-asserted-by":"crossref","unstructured":"BMJ Publishing Group Ltd BMA House, Square T, London, 9jr W. 2017 European Glaucoma Society Terminology and Guidelines for Glaucoma 4th Edition - Chapter 2: classification and terminology, Br J Ophthalmol, 101:73\u2013127","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.002"},{"key":"2717_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/IJG.0b013e3181aff432","volume":"19","author":"P Fogagnolo","year":"2010","unstructured":"Fogagnolo P, Capizzi F, Orzalesi N et al (2010) Can mean central corneal thickness and its 24-hour fluctuation influence fluctuation of intraocular pressure? J Glaucoma 19:418\u2013423","journal-title":"J Glaucoma"},{"key":"2717_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/tvst.5.5.4","volume":"5","author":"S McCafferty","year":"2016","unstructured":"McCafferty S, Lim G, Duncan W et al (2016) Goldmann tonometer prism with an optimized error correcting applanation surface. Transl Vis Sci Technol 5:4","journal-title":"Transl Vis Sci Technol"},{"key":"2717_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1442-9071.2012.02870.x","volume":"41","author":"D Viswanathan","year":"2013","unstructured":"Viswanathan D, Goldberg I, Graham SL et al (2013) Longitudinal effect of topical antiglaucoma medications on central corneal thickness. Clin Experiment Ophthalmol 41:348\u2013354","journal-title":"Clin Experiment Ophthalmol"},{"key":"2717_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/IJG.0000000000000190","volume":"25","author":"WA Schrems","year":"2016","unstructured":"Schrems WA, Schrems-Hoesl LM, Mardin CY et al (2016) The effect of long-term antiglaucomatous drug administration on central corneal thickness. J Glaucoma 25:274\u2013280","journal-title":"J Glaucoma"},{"key":"2717_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/exer.1998.0508","volume":"67","author":"A Ocklind","year":"1998","unstructured":"Ocklind A (1998) Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Exp Eye Res 67:179\u2013191","journal-title":"Exp Eye Res"},{"key":"2717_CR29","first-page":"2772","volume":"38","author":"RN Weinreb","year":"1997","unstructured":"Weinreb RN, Kashiwagi K, Kashiwagi F et al (1997) Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci 38:2772\u20132780","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2717_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/jop.2012.0080","volume":"29","author":"JY You","year":"2013","unstructured":"You JY, Cho BJ (2013) Effect of latanoprost on central corneal thickness in unilateral normal-tension glaucoma. J Ocul Pharmacol Ther 29:335\u2013338","journal-title":"J Ocul Pharmacol Ther"},{"key":"2717_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3341\/kjo.2019.0129","volume":"34","author":"M Jang","year":"2020","unstructured":"Jang M, Kang KE, Cho BJ (2020) Effect of prostaglandin analogues on central corneal thickness: 3-year follow-up results. Korean J Ophthalmol 34:347\u2013352","journal-title":"Korean J Ophthalmol"},{"key":"2717_CR32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/ICO.0b013e3182000c27","volume":"30","author":"Y Zhong","year":"2011","unstructured":"Zhong Y, Shen X, Yu J et al (2011) The comparison of the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness. Cornea 30:861\u2013864","journal-title":"Cornea"},{"key":"2717_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/01.ijg.0000212210.33265.24","volume":"15","author":"Y Liu","year":"2006","unstructured":"Liu Y, Yanai R, Lu Y et al (2006) Effects of antiglaucoma drugs on collagen gel contraction mediated by human corneal fibroblasts. J Glaucoma 15:255\u2013259","journal-title":"J Glaucoma"},{"key":"2717_CR34","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1167\/iovs.06-0036","volume":"47","author":"DJ Oh","year":"2006","unstructured":"Oh DJ, Martin JL, Williams AJ et al (2006) Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 47:3887\u20133895","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2717_CR35","doi-asserted-by":"publisher","first-page":"1015338","DOI":"10.3389\/fphar.2022.1015338","volume":"13","author":"L Zhou","year":"2022","unstructured":"Zhou L, Zhan W, Wei X (2022) Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma. Front Pharmacol 13:1015338","journal-title":"Front Pharmacol"},{"key":"2717_CR36","doi-asserted-by":"publisher","first-page":"27147","DOI":"10.1074\/jbc.272.43.27147","volume":"272","author":"P Kunapuli","year":"1997","unstructured":"Kunapuli P, Lawson JA, Rokach J et al (1997) Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor Activation by the isoprostane 12-iso-PGF2alpha. J Biol Chem 272:27147\u201327154","journal-title":"J Biol Chem"},{"key":"2717_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1755-3768.1975.tb01135.x","volume":"53","author":"N Ehlers","year":"1975","unstructured":"Ehlers N, Bramsen T, Sperling S (1975) Applanation tonometry and central corneal thickness. Acta Ophthalmol 53:34\u201343","journal-title":"Acta Ophthalmol"},{"key":"2717_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/15569527.2019.1590390","volume":"38","author":"E Sen","year":"2019","unstructured":"Sen E, Inanc M, Elgin U (2019) The effect of topical latanoprost on corneal clarity; 1-year prospective study. Cutan Ocul Toxicol 38:253\u2013257","journal-title":"Cutan Ocul Toxicol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02717-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-023-02717-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02717-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T04:03:40Z","timestamp":1691035420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-023-02717-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["2717"],"URL":"https:\/\/doi.org\/10.1007\/s10792-023-02717-y","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. The authors indicate no financial support or financial conflict of interest. The authors have indicated they have no financial relationships with any company and no external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}